文献速递心境障碍焦虑、强迫与应激相关障碍

基于脑环路的神经调控:不同抑郁症状对应不同治疗靶点

Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation.
PubMed 文献 · Am J Psychiatry · 2020-03-12

该研究回顾性分析接受左前额叶经颅磁刺激(TMS)治疗抑郁的患者(发现样本N=30,活性复制样本N=81,假刺激复制样本N=87),利用功能连接MRI将TMS位点映射到脑环路。结果发现两个不同的环路靶点分别对应两组抑郁症状:烦躁症状(如悲伤、快感缺失)对其中一个环路刺激反应最佳,焦虑和躯体症状对另一个环路刺激反应最佳;这些环路图可重复、能预测独立队列的症状改善且具有活性刺激特异性。

要点

  • 抑郁的不同症状簇对应不同的脑刺激环路靶点。
  • 烦躁症状与焦虑/躯体症状的最佳刺激环路不同。
  • 症状特异性靶点图可预测独立队列及14项临床试验的症状改善。

核心结论

  • 不同抑郁症状簇对不同的TMS靶点反应更好,症状特异性靶点可在随机临床试验中前瞻性验证。

研究设计与样本

  • 回顾性分析两个独立队列的抑郁患者,均接受左前额叶TMS治疗(发现样本N=30,活性复制样本N=81,假刺激复制样本N=87)。
  • 使用大型连接组数据库(N=1,000)的功能连接MRI将每位患者的TMS位点映射到 underlying 脑环路。
  • 识别与各抑郁症状改善相关的环路,基于相似性聚类,并检验跨数据集可重复性及交叉预测能力。

主要发现

  • 识别出两个不同的环路靶点,分别对两组离散的抑郁症状有效。
  • 烦躁症状(如悲伤和快感缺失)对其中一个环路刺激反应最佳,焦虑和躯体症状对另一个环路刺激反应最佳。
  • 这些环路图可重复,能预测独立患者队列的症状改善,且具有活性刺激特异性(对比假刺激)。
  • 在14项临床TMS试验刺激位点的探索性分析中,这些图可预测症状改善。

临床怎么用

  • 可根据患者具体症状簇(烦躁 vs 焦虑/躯体)选择不同的TMS环路靶点,以提升疗效并推动个体化治疗。

局限性

  • 研究为回顾性分析,症状特异性靶点需前瞻性随机临床试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Treatment of different depression symptoms may require different brain stimulation targets with different underlying brain circuits. The authors sought to identify such targets, which could improve the efficacy of therapeutic brain stimulation and facilitate personalized therapy. METHODS: The authors retrospectively analyzed two independent cohorts of patients who received left prefrontal transcranial magnetic stimulation (TMS) for treatment of depression (discovery sample, N=30; active replication sample, N=81; sham replication sample, N=87). Each patient's TMS site was mapped to underlying brain circuits using functional connectivity MRI from a large connectome database (N=1,000). Circuits associated with improvement in each depression symptom were identified and then clustered based on similarity. The authors tested for reproducibility across data sets and whether symptom-specific targets derived from one data set could predict symptom improvement in the other independent cohort. RESULTS: The authors identified two distinct circuit targets effective for two discrete clusters of depressive symptoms. Dysphoric symptoms, such as sadness and anhedonia, responded best to stimulation of one circuit, while anxiety and somatic symptoms responded best to stimulation of a different circuit. These circuit maps were reproducible, predicted symptom improvement in independent patient cohorts, and were specific to active compared with sham stimulation. The maps predicted symptom improvement in an exploratory analysis of stimulation sites from 14 clinical TMS trials. CONCLUSIONS: Distinct clusters of depressive symptoms responded better to different TMS targets across independent retrospective data sets. These symptom-specific targets can be prospectively tested in a randomized clinical trial. This data-driven approach for identifying symptom-specific targets may prove useful for other disorders and facilitate personalized neuromodulation therapy.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Siddiqi SH, Taylor SF, Cooke D, et al. Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation. Am J Psychiatry. 2020. PMID: 32160765. doi:10.1176/appi.ajp.2019.19090915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。